Shreyas Intermediates Ltd (SHREYASI) — shareholding pattern, promoter holding, financials and share price
About Shreyas Intermediates Ltd (SHREYASI)
Shreyas Intermediates Ltd operates in the Commodity Chemicals industry, within the Chemicals sector. It trades on the NSE as SHREYASI and on the BSE under scrip code 526335. Its ISIN is INE115F01017.
Incorporated in 1992, Shreyas Intermediates Ltd is a manufacturer of Phthalocyanine Blue Crude and its downstream products. [1]
Shreyas Intermediates Limited is a manufacturing company specializing in dyes, pigments, and pigment intermediates. Founded in 1989 and went public in 1992, it has expanded into producing CPC Blue and CPC Green with export potential in the US and Germany.
The company had initially ventured into H-Acid production but shifted focus due to profitability issues, converting the plant for pigment manufacturing in the early 2000s.
Listed peers in Commodity Chemicals: Shentracon Chemicals Ltd, Standard Surfactants Ltd, TCM Ltd, Tulasee Bio-Ethanol Ltd, Camex Ltd, Haryana Leather Chemicals Ltd.
Valuation & Returns
10 Jul 2026At ₹5.72 a share on 10 Jul 2026, Shreyas Intermediates Ltd (SHREYASI) was valued at a price-to-earnings ratio of -152.85x and a price-to-book of 3.27x on a book value of ₹1.75 per share as of Mar 2025. Solomo computes return on equity of -10.09% and return on capital employed of -5.18% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -152.85x
- P/B
- 3.27x
- EPS (TTM)
- ₹-0.18
- Book value / share
- ₹1.75
- ROE
- -10.09%
- ROCE
- -5.18%
- ROA
- -4.7%
- Debt / equity
- 0.95x
- Dividend yield
- 0%
- EBITDA margin
- -660%
- 52-week range
- ₹16.65 – ₹113.65
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Shreyas Intermediates Ltd (SHREYASI) reported revenue of ₹16.69 crore, net profit of ₹-1.26 crore and earnings per share of ₹-0.18. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, net profit ₹-0.28 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 0 | 0 | 0 | 0 | 16.69 |
| Net profit (₹ cr) | -1.35 | -1.57 | -1.58 | -1.59 | -1.26 |
| EPS (₹) | -0.19 | -0.22 | -0.22 | -0.22 | -0.18 |
| Measure | 1Y |
|---|---|
| Profit growth | -0.63% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 57.21% of Shreyas Intermediates Ltd (SHREYASI) (unchanged from the previous quarter), foreign institutional investors (FII) hold 8.39% and domestic institutional investors (DII) hold 0%. Promoters have pledged 10% of their holding. Market capitalisation was ₹41 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: KRISH PHARMA SPECIALITY PRIVATE LIMITED- ESCROW DEMAT ACCOUN 24.7%, AEGIS INVESTMENT FUND PCC 8.39%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 57.21% | 10% | 8.39% | 0% | 42.79% |
| Mar 2026 | 57.21% | 10% | 8.39% | 0% | 42.79% |
| Dec 2025 | 57.21% | 10% | 8.39% | 0% | 42.79% |
| Sep 2025 | 57.21% | 10% | 8.42% | 0% | 42.79% |
| Jun 2025 | 57.21% | 10% | 8.53% | 0% | 42.79% |
| Mar 2025 | 57.21% | 10% | 8.53% | 0% | 42.79% |
| Dec 2024 | 57.21% | 10% | 8.54% | 0% | 42.79% |
| Sep 2024 | 57.21% | 0.7% | 9.46% | 0% | 42.79% |